Bio-Raid

banner

Time of issue:2019-07-09 00:00:00

 
这是描述信息
Homepage
/
News
/
Company news
/
The National Development and Reform Commission High Technology Department visited our company
Check category

The National Development and Reform Commission High Technology Department visited our company

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2019-02-21 14:34
  • Views:7

(Summary description)On February 20, 2019, Li Shuai, deputy researcher of the Second Division of the New Industry Division of the National Development and Reform Commission, and the representative of the Innovation Capacity Division visited the company for investigation and research, and highly praised the company's achievements in cancer treatment. Cai Li, Director of the High Technology Department of the Hubei Provincial Development and Reform Commission, and Feng Li, Chief Engineer of the Donghu High-tech Zone Management Committee, accompanied the delegation.

The National Development and Reform Commission High Technology Department visited our company

(Summary description)On February 20, 2019, Li Shuai, deputy researcher of the Second Division of the New Industry Division of the National Development and Reform Commission, and the representative of the Innovation Capacity Division visited the company for investigation and research, and highly praised the company's achievements in cancer treatment. Cai Li, Director of the High Technology Department of the Hubei Provincial Development and Reform Commission, and Feng Li, Chief Engineer of the Donghu High-tech Zone Management Committee, accompanied the delegation.

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2019-02-21 14:34
  • Views:7
Information
On February 20, 2019, Li Shuai, deputy researcher of the Second Division of the New Industry Division of the National Development and Reform Commission, and the representative of the Innovation Capacity Division visited the company for investigation and research, and highly praised the company's achievements in cancer treatment. Cai Li, Director of the High Technology Department of the Hubei Provincial Development and Reform Commission, and Feng Li, Chief Engineer of the Donghu High-tech Zone Management Committee, accompanied the delegation.
The National Development and Reform Commission High Technology Department visited our company

The National Development and Reform Commission High Technology Department visited our company
The leaders listened carefully to the company's chairman for the introduction of CAR-T core technology.
Li Shuai said that in response to the 13th Five-Year Bio-Industry Planning Requirements, the State is actively preparing to build an immune cell engineering technology demonstration center. The supporting center will introduce standardized immune cell preparation and testing processes, promote the construction of quality systems, and promote the development of the entire industry. Porida Bio should accelerate the process of new drug declaration and achieve drug listing as soon as possible.
The National Development and Reform Commission High Technology Department visited our company
As the most representative immune cell therapy company in Central China, Boruida Biotechnology has an immune cell therapy technology platform for complete production lines such as plasmid preparation, lentiviral packaging and cell production, and the company's independently developed cell cryopreservation technology for patients. Provide safe, reliable cell products.
At present, the company has completed nearly 400 clinical cases in cooperation with medical institutions such as Optics Valley Tongji Hospital, and the treatment effect is very significant, which has played a positive role in the development of the industry. In addition, the company has completed a new drug declaration.
In the application of CAR-T technology for the treatment of HIV infection, Porida Biotech took the lead in conducting clinical research globally, and the innovative technology research and development results obtained the first invention patent authorization, and the patent layout was carried out in the United States, Europe and Japan. Advanced technology and excellent development platform provide strong technical support for the company's long-term development.
The National Development and Reform Commission High Technology Department visited our company
Feng Li said that the Donghu High-tech Zone Management Committee has issued a series of policies to do a good job in supporting industrial services and concentrate on supporting enterprises to develop better and faster. At present, Donghu High-tech Zone is accelerating the construction of an immune cell sample bank to promote the development of the immune cell therapy technology industry.
Immune cell therapy has ushered in the spring of development. Chairman Zhang Tongcun said: Under the government's policy of building a cell therapy technology demonstration center, the company will continue its technological innovation and promote the application of immune cell therapy technology. Realize technology transfer, strengthen cooperation with hospitals, and provide safer and more effective services for more patients.
The National Development and Reform Commission High Technology Department visited our company
 

Scan the QR code to read on your phone

Previous: Provincial Department of Organizational Department special investigation Zhang Tongcun Professor CAR-T results transformation
Next: Chen Anli, deputy governor of Hubei Province, praised Porida Bio Company
Previous: Provincial Department of Organizational Department special investigation Zhang Tongcun Professor CAR-T results transformation
Next: Chen Anli, deputy governor of Hubei Province, praised Porida Bio Company
Bio-Raid

Wuhan Bio-Raid Biotechnology Co., Ltd.

 

Company address : 388 gaoxin 2nd road, east lake new technology development zone, wuhan city Floor 4, building 3, phase 3.1, wuhan optical valley international bio-pharmaceutical enterprise accelerator  Floor 5-1
Phone number :  086-027-59318269
E-mail：cart@bio-raid.com

 

Bio-Raid

Contact

© Wuhan Bio-Raid Biotechnology Co.,Ltd.  www.300.cn 鄂ICP备16000510号-1